Alpha 2.0
Login Register
» Authors » Bettina Winzeler

Bettina Winzeler

Explore the profile of Bettina Winzeler including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 59
Citations 714
Followers 0
Related Specialties
Endocrinology
General Medicine
Pharmacology
Top 10 Co-Authors
Mirjam Christ-Crain
Julie Refardt
Clara O Sailer
Deborah R Vogt
Philipp Schuetz
Nicole Nigro
Beat Mueller
Sandrine A Urwyler
Birsen Arici
Sophia Lengsfeld
Published In
J Clin Endocrinol Metab
Clin Endocrinol (Oxf)
Eur J Endocrinol
Lancet
Swiss Med Wkly
Affiliations
Soon will be listed here.
Recent Articles
1.
Blood pressure changes during smoking cessation in a randomized, double-blind, placebo-controlled trial of dulaglutide treatment
Beck J, Hasenbohler F, Werlen L, Lengsfeld S, Meienberg A, Bathelt C, et al.
Eur J Prev Cardiol . 2025 Mar; PMID: 40037282
Aims: Cigarette smoking cessation reduces cardiovascular risk via various mechanisms. Thereby, the role of blood pressure remains unclear, with studies reporting both decreased and increase blood pressure values after cessation,...
2.
Relationship between plasma urea and copeptin in response to arginine stimulation in healthy adults, patients with vasopressin deficiency and primary polydipsia
Atila C, Lustenberger S, Chifu I, Ferrante E, Erlic Z, Drummond J, et al.
Pituitary . 2025 Jan; 28(1):18. PMID: 39863827
Background: Arginine infusion stimulates copeptin secretion, a surrogate marker of arginine vasopressin (AVP), thereby serving as a diagnostic test in the differential diagnosis of suspected AVP deficiency (AVP-D). Yet, the...
3.
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
Lengsfeld S, Probst L, Emara Y, Werlen L, Vogt D, Bathelt C, et al.
EBioMedicine . 2024 Sep; 107:105284. PMID: 39232425
Background: The reward-regulatory properties of GLP-1 are attracting increasing interest. Animal studies show that GLP-1 receptor agonists not only reduce consumption of addictive substances, but also influence sexual behaviour. We...
4.
Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls
Atila C, Beck J, Refardt J, Erlic Z, Drummond J, Sailer C, et al.
Eur J Endocrinol . 2024 Mar; 190(5):354-362. PMID: 38551325
Objective: Distinguishing arginine vasopressin deficiency (AVP-D; central diabetes insipidus) from primary polydipsia (PP), commonly referred to as psychogenic polydipsia, is challenging. Psychopathologic findings, commonly used for PP diagnosis in clinical...
5.
Effect of dulaglutide in promoting abstinence during smoking cessation: 12-month follow-up of a single-centre, randomised, double-blind, placebo-controlled, parallel group trial
Luthi H, Lengsfeld S, Burkard T, Meienberg A, Jeanloz N, Vukajlovic T, et al.
EClinicalMedicine . 2024 Feb; 68:102429. PMID: 38371479
Background: Smoking cessation is challenging, despite making use of established smoking cessation therapies. Preclinical studies and one clinical pilot study suggest the antidiabetic drug glucagon-like peptide-1 (GLP-1) analogue to modulate...
6.
Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trial
Baur F, Atila C, Lengsfeld S, Burkard T, Meienberg A, Bathelt C, et al.
BMJ Nutr Prev Health . 2024 Jan; 6(2):301-309. PMID: 38264360
Background: Women seem to have more difficulty quitting smoking than men. This is particularly concerning as smoking puts women at a higher risk of developing smoking-associated diseases. Greater concerns about...
7.
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
Blum C, Roethlisberger E, Cesana-Nigro N, Winzeler B, Rodondi N, Blum M, et al.
BMC Pulm Med . 2023 Dec; 23(1):500. PMID: 38082273
Background: Several trials and meta-analyses found a benefit of adjunct corticosteroids for community-acquired pneumonia with respect to short-term outcome, but there is uncertainty about longer-term health effects. Herein, we evaluated...
8.
Effects of dulaglutide on alcohol consumption during smoking cessation
Probst L, Monnerat S, Vogt D, Lengsfeld S, Burkard T, Meienberg A, et al.
JCI Insight . 2023 Nov; 8(22). PMID: 37991022
BACKGROUNDAlcohol use disorder has a detrimental impact on global health and new treatment targets are needed. Preclinical studies show attenuating effects of glucagon-like peptide-1 (GLP-1) agonists on addiction-related behaviors in...
9.
Arginine or Hypertonic Saline-Stimulated Copeptin to Diagnose AVP Deficiency
Refardt J, Atila C, Chifu I, Ferrante E, Erlic Z, Drummond J, et al.
N Engl J Med . 2023 Nov; 389(20):1877-1887. PMID: 37966286
Background: Distinguishing between arginine vasopressin (AVP) deficiency and primary polydipsia is challenging. Hypertonic saline-stimulated copeptin has been used to diagnose AVP deficiency with high accuracy but requires close sodium monitoring....
10.
Sensitivity, specificity, and diagnostic accuracy of WHO 2013 criteria for diagnosis of gestational diabetes mellitus in low risk early pregnancies: international, prospective, multicentre cohort study
Huhn E, Gobl C, Fischer T, Todesco Bernasconi M, Kreft M, Kunze M, et al.
BMJ Med . 2023 Sep; 2(1):e000330. PMID: 37720695
Objective: To evaluate the predictability of gestational diabetes mellitus wth a 75 g oral glucose tolerance test (OGTT) in early pregnancy, based on the 2013 criteria of the World Health...